View of Cardiovascular Benefits and Pharmacological Mechanisms of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Narrative Review

Return to Article Details Cardiovascular Benefits and Pharmacological Mechanisms of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Narrative Review Download Download PDF